98 related articles for article (PubMed ID: 1378646)
1. [Female contraception by a normal dose progestogen after 40 years of age. Possible association of nomegestrol--17-beta-estradiol acetate by percutaneous route].
Jamin C
Rev Fr Gynecol Obstet; 1992 Jun; 87(6):370-6. PubMed ID: 1378646
[TBL] [Abstract][Full Text] [Related]
2. [High-dose progestational contraception: advantages].
Jamin C
Contracept Fertil Sex; 1993 Feb; 21(2):123-8. PubMed ID: 7524930
[TBL] [Abstract][Full Text] [Related]
3. [High-dose progestational contraception: advantages].
Jamin C
Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318010
[TBL] [Abstract][Full Text] [Related]
4. [Macroprogestative contraception: advantages].
Jamin C
Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318009
[TBL] [Abstract][Full Text] [Related]
5. Nomegestrol acetate/estradiol: in oral contraception.
Yang LP; Plosker GL
Drugs; 2012 Oct; 72(14):1917-28. PubMed ID: 22950535
[TBL] [Abstract][Full Text] [Related]
6. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT
Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
[TBL] [Abstract][Full Text] [Related]
7. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
8. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
Rozenbaum H
Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive implants.
Ladipo O; Coutinho EM
Curr Opin Obstet Gynecol; 1994 Dec; 6(6):564-9. PubMed ID: 7893965
[TBL] [Abstract][Full Text] [Related]
10. [Pills and minipills].
Koffel JC
Bull Soc Pharm Strasb; 1978; 21(1):43-53. PubMed ID: 12261367
[TBL] [Abstract][Full Text] [Related]
11. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
12. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
[TBL] [Abstract][Full Text] [Related]
13. Nomegestrol acetate, a novel progestogen for oral contraception.
Mueck AO; Sitruk-Ware R
Steroids; 2011 May; 76(6):531-9. PubMed ID: 21335021
[TBL] [Abstract][Full Text] [Related]
14. [Use of nomegestrol acetate in the treatment of menstruation disorders. Our experience in 56 cases].
Persiani P; Radici E; Lombardi PA; Lombardi PL
Minerva Ginecol; 1997 Apr; 49(4):181-5. PubMed ID: 9206771
[TBL] [Abstract][Full Text] [Related]
15. Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy.
Lello S
Drugs; 2010 Mar; 70(5):541-59. PubMed ID: 20329803
[TBL] [Abstract][Full Text] [Related]
16. Nomegestrol acetate contraceptive implant use by women with sickle cell disease.
Nascimento Mde L; Ladipo OA; Coutinho EM
Clin Pharmacol Ther; 1998 Oct; 64(4):433-8. PubMed ID: 9797800
[TBL] [Abstract][Full Text] [Related]
17. [Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate].
Pintiaux A; Gaspard U; Nisolle M
Rev Med Liege; 2012 Mar; 67(3):152-6. PubMed ID: 22611833
[TBL] [Abstract][Full Text] [Related]
18. [Contraception using normal dose progestins].
Pelissier-langbort C
Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1099-109. PubMed ID: 12266559
[TBL] [Abstract][Full Text] [Related]
19. [Lutenyl and menstrual disorders. A hospital study].
Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
[TBL] [Abstract][Full Text] [Related]
20. [Biological and clinical safety of nomegestrol acetate administered alone then associated in inverse sequence with transdermal 17 beta estradiol, in women at risk of dyslipoproteinemia type IIa].
Zartarian M; Chevallier T; Micheletti MC; Leber C; Jamin C
Ann Endocrinol (Paris); 1998 Dec; 59(5):411-6. PubMed ID: 9949893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
